Upper gastrointestinal tract

John O. Clarke*, Ikuo Hirano

*Corresponding author for this work

Research output: Chapter in Book/Report/Conference proceedingChapter

Abstract

Systemic sclerosis (SSc) is a chronic connective tissue disorder with multisystem involvement. The gastrointestinal (GI) tract is affected in up to 90% of patients [1-3] and gut involvement is a leading cause of morbidity. Symptoms vary based on location of involvement and degree of impairment; however, dysphagia, reflux, nausea, vomiting, pain, diarrhea, constipation, fecal incontinence, and weight loss are commonly reported. GI involvement severely impacts quality of life and is a major cause of morbidity and mortality associated with SSc [4]. While the esophagus is the most widely described site of GI involvement, SSc can affect any site within the GI tract from the mouth to the anus. This chapter will focus on foregut manifestations of SSc, ranging from the mouth to stomach with an emphasis on both motility and bleeding. Involvement of other regions of the GI tract will be detailed in other chapters.

Original languageEnglish (US)
Title of host publicationScleroderma
Subtitle of host publicationFrom Pathogenesis to Comprehensive Management
PublisherSpringer US
Pages471-484
Number of pages14
ISBN (Electronic)9781441957740
ISBN (Print)9781441957733
DOIs
StatePublished - Jan 1 2012

Keywords

  • Diagnostic evaluation
  • Esophagus
  • Oropharyngeal cavity
  • Relationship to pulmonary disease
  • Stomach
  • Treatment
  • Upper gastrointestinal tract

ASJC Scopus subject areas

  • Medicine(all)

Fingerprint

Dive into the research topics of 'Upper gastrointestinal tract'. Together they form a unique fingerprint.

Cite this